Ali G. Hamedani, MD, MHS
he/his
Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
View 1 additional location
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Assistant Professor of Neurology at the Hospital of the University of Pennsylvania
  • Assistant Professor of Epidemiology in Biostatistics and Epidemiology
  • Assistant Professor of Neurology in Ophthalmology

Education and training

  • Medical School: University of Maryland School of Medicine
  • Residency: University of Pennsylvania Health System

What my patients think about me

Average Rating

190 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

December 2025
excellent care
December 2025
he listens to any concerns you may have regarding your health.
October 2025
don't get answers
October 2025
felt dismissed . not heard regarding symptoms.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Hamedani is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Anthony CM, Liu GT, Hamedani AG Case-Only Study Designs in Neuro-Ophthalmology: An Example Using Pseudotumor Cerebri Syndrome , North American Neuro-Ophthalmology Society: 2026

Morano MJ, Narayanaswami P, Hamedani AG Non-ocular symptoms in early, treatment-naïve ocular myasthenia gravis: the PROMISE-MG study , North American Neuro-Ophthalmology Society: 2026

Magee RG, Li Y, Rovine MJ, Pelak VS, Hamedani AG Epidemiology of visuospatial impairment in older adults: the Harmonized Cognitive Assessment Protocol , North American Neuro-Ophthalmology Society: 2026

Cordisco AJ, Jin F, Hamedani AG, VanderBeek BL Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis , North American Neuro-Ophthalmology Society: 2026

Xu AL, Li M, Gupta AS, Morton SM, Hamedani AG Visual scanning and falls in older adults: the Mexico Health and Aging Study , Journal of the American Geriatrics Society: 2025

Yu HN, He j, Hamedani AG, Ying GS Ophthalmic Conditions in Patients with Multiple Sclerosis , Multiple Sclerosis and Related Disorders: 2025

Pham K, Salowe R, Di Rosa R, Hamedani AG, Ying GS, O’Brien JM The association between glaucoma and dementia in a national cohort of All of Us participants , Ophthalmology: 2025

Lin Y, Amokrane N, Worley S, Moore L, Rosen A, Crespo L, Trace K, Ashizawa T, Billnitzer A, Perlman S, Bushara K, Geschwind MD, Dietiker C, Gomez CM, Padmanaban M, Opal P, Akhtar R, Paulson H, Srinivasan S, Ferng A, Ferrari F, Onyike CU, Fishman A, Ying S, Paul A, Schmahmann JD, Stephen CM, Gupta A, Lin CC, Subramony SH, Burns M, Wilmot G, Duquette D, Zesiewicz T, Davis MT, Hamedani AG, Vizcarra Pasapera JA, Pulst S, Primeaux S, Öz G, Shakkottai V, Rosenthal LS, Kuo SH on behalf of CRC-SCA Consortium The Natural History Study and Biomarker Collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA) , Cerebellum, 24(5): 2025,134

Hamedani AG, Thibault DP, Rascovsky K, Willis AW, Langa KM Comparing retrospective informant assessments to prospectively collected cognitive measures in the Health and Retirement Study , Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 17(3): 2025,e70138

Lawton C, Mendoza M, Hamedani AG, Wolfe GI, Suh J, Kupersmith M, Barnett-Tapia C Evaluation of Measures for Ocular Manifestations in Myasthenia Gravis , Myasthenia Gravis Foundation of America: 2025